Bernstein SocGen's Thoughts on Abbvie (ABBV) Following APGE Acquisition
Tweet Send to a Friend
Bernstein SocGen Group analyst Courtney Breen reiterated a Market Perform rating and $225.00 price target on Abbvie (NYSE: ABBV).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
